Christopher D Alafi - Insider Trading Tracker

Stereotaxis, Inc.

US ˙ NYSEAM ˙ US85916J4094

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Christopher D Alafi. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Christopher D Alafi telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:ITCI / Intra-Cellular Therapies, Inc.	Director	95,000
US:STXS / Stereotaxis, Inc.	10% Owner	1,266,628

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Christopher D Alafi. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam STXS / Stereotaxis, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam STXS / Stereotaxis, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2012-05-10	STXS	Alafi Christopher D	8,674,908		8,674,908			0	3.2029

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam STXS / Stereotaxis, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam STXS / Stereotaxis, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2013-08-20 STXS Alafi Christopher D 22,220 3.7000 22,220 3.7000 82,214 353 2.7450 -21,220 -25.81

2013-08-19 STXS Alafi Christopher D 239,021 3.7430 239,021 3.7430 894,656

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Christopher D Alafi seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2021-05-28 2021-05-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock S - Sale X -38,843 95,000 -29.02 40.12 -1,558,381 3,811,400

2021-05-28 2021-05-27 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock S - Sale X -8,482 133,843 -5.96 40.01 -339,365 5,355,058

2021-05-25 2021-05-24 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock S - Sale X -26,575 142,325 -15.73 40.47 -1,075,490 5,759,893

2021-05-25 2021-05-21 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock S - Sale X -1,100 168,900 -0.65 40.00 -44,000 6,756,000

2021-04-02 2021-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 464 346,795 0.13 33.93 15,744 11,766,754

2021-01-05 2020-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 495 346,331 0.14 31.80 15,741 11,013,326

2020-10-02 2020-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 613 345,836 0.18 25.66 15,730 8,874,152

2020-09-14 2020-09-14 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 49,500 4,743,770 1.05 29.60 1,465,200 140,415,592

2020-09-11 2020-09-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 21,000 4,694,270 0.45 28.08 589,680 131,815,102

2020-07-02 2020-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 613 345,223 0.18 25.67 15,736 8,861,874

2020-05-28 2020-05-27 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2020-04-02 2020-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,024 344,610 0.30 15.37 15,739 5,296,656

2020-01-03 2019-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 422 343,586 0.12 34.31 14,479 11,788,436

2019-10-02 2019-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,941 343,164 0.57 7.47 14,499 2,563,435

2019-09-11 2019-09-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 6,240 4,673,270 0.13 11.00 68,640 51,405,970

2019-09-11 2019-09-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 320,095 4,667,030 7.36 10.58 3,386,605 49,377,177

2019-09-11 2019-09-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 155,116 4,346,935 3.70 9.59 1,487,562 41,687,107

2019-09-11 2019-09-10 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 3,549 4,191,819 0.08 8.98 31,870 37,642,535

2019-09-04 2019-08-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 125,000 4,188,270 3.08 8.52 1,065,212 35,691,180

2019-07-02 2019-06-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,117 341,223 0.33 12.98 14,499 4,429,075

2019-06-26 2019-06-25 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2019-06-19 2019-06-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock G - Gift -400,000 340,106 -54.05

2019-06-19 2017-11-22 4/A ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 10,000 3,963,270 0.25 15.55 155,500 61,628,848

2019-06-14 2019-06-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 58,705 170,000 52.75 12.00 704,460 2,040,000

2019-06-14 2019-06-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 95,069 111,295 585.91 11.70 1,112,307 1,302,152

2019-06-14 2019-06-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 16,226 16,226 10.91 177,026 177,026

2019-05-15 2019-05-14 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 100,000 4,053,270 2.53 12.56 1,256,350 50,923,258

2019-04-02 2019-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,190 750,106 0.16 12.18 14,494 9,136,291

2019-01-03 2018-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,273 748,916 0.17 11.39 14,499 8,530,153

2018-10-02 2018-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 668 747,643 0.09 21.70 14,496 16,223,853

2018-07-03 2018-06-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 820 746,975 0.11 17.67 14,489 13,199,048

2018-06-20 2018-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2018-04-03 2018-03-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 688 746,155 0.09 21.05 14,482 15,706,563

2018-01-03 2017-12-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 1,001 745,467 0.13 14.48 14,494 10,794,362

2018-01-03 2017-12-29 4/A ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,001 745,467 0.13 14.48 14,494 10,794,362

2017-11-27 2017-11-22 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 10,000 744,466 1.36 15.55 155,500 11,576,446

2017-10-03 2017-10-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 258,065 3,953,270 6.98 15.50 4,000,008 61,275,685

2017-10-03 2017-09-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 918 734,466 0.13

2017-07-05 2017-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,167 733,548 0.16

2017-06-29 2017-06-27 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2017-04-04 2017-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 892 732,381 0.12

2017-01-03 2016-12-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 960 731,489 0.13

2016-12-07 2016-12-07 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 20,826 3,695,205 0.57 16.14 336,038 59,623,980

2016-12-07 2016-12-06 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 44,174 3,674,379 1.22 16.33 721,445 60,009,590

2016-11-17 2016-11-14 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 34,000 3,630,205 0.95 14.50 492,969 52,634,705

2016-10-04 2016-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 951 730,529 0.13

2016-07-05 2016-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 373 729,578 0.05

2016-06-15 2016-06-14 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2016-04-04 2016-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 377 729,205 0.05

2016-02-29 2016-02-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 100,000 728,828 15.90 29.70 2,970,300 21,648,378

2016-01-05 2015-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 195 628,828 0.03 53.79 10,489 33,824,658

2015-10-02 2015-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 262 628,633 0.04

2015-07-02 2015-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 328 628,371 0.05

2015-06-22 2015-06-16 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2015-04-02 2015-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 439 628,043 0.07

2015-03-12 2015-03-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 625,000 627,604 24,001.54 24.00 15,000,000 15,062,496

2015-01-05 2014-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 594 2,604 29.55

2014-12-03 2014-12-01 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 1,422 3,596,205 0.04 14.75 20,974 53,044,024

2014-11-28 2014-11-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 35,000 3,594,783 0.98 14.75 516,250 53,023,049

2014-11-21 2014-11-19 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 1,034 3,559,783 0.03 14.25 14,734 50,726,908

2014-11-18 2014-11-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 3,531 3,558,749 0.10 14.23 50,246 50,640,998

2014-11-18 2014-11-14 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 133 3,555,218 0.00 15.07 2,004 53,577,135

2014-11-13 2014-11-13 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 2,200 3,555,085 0.06 15.12 33,264 53,752,885

2014-11-13 2014-11-12 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 5,000 3,552,885 0.14 15.23 76,150 54,110,439

2014-11-13 2014-11-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock P - Purchase 5,000 3,547,885 0.14 15.55 77,750 55,169,612

2014-10-02 2014-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 765 2,010 61.45

2014-07-02 2014-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy) A - Award 20,000 20,000

2014-07-02 2014-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock A - Award 1,245 1,245

2013-09-09 3 NONE Intra-Cellular Therapies, Inc.
Common Stock 3,542,885

2013-09-09 3 NONE Intra-Cellular Therapies, Inc.
Common Stock 503,753

2013-08-20 2013-08-20 4 STXS Stereotaxis, Inc.
Common Stock S - Sale -22,220 1,266,628 -1.72 3.70 -82,214 4,686,524

2013-08-20 2013-08-19 4 STXS Stereotaxis, Inc.
Common Stock S - Sale -239,021 1,288,848 -15.64 3.74 -894,656 4,824,158

2013-08-20 2013-08-16 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) M - Exercise -261,241 606,249 -30.11 3.36 -878,031 2,037,603

2013-08-20 2013-08-16 4 STXS Stereotaxis, Inc.
Common Stock M - Exercise 261,241 1,527,869 20.62 3.36 878,031 5,135,168

2013-08-15 2013-07-31 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) J - Other -4,771 4,771 -50.00

2013-08-15 2013-06-28 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) J - Other -16,129 16,129 -50.00

2012-05-14 2012-05-10 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) P - Purchase 8,674,908 8,674,908

2012-05-14 2012-05-10 4 STXS Stereotaxis, Inc.
Common Stock P - Purchase 8,674,908 12,666,281 217.34

2012-05-14 2012-05-07 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) J - Other 781,018 781,018

2012-05-03 2012-05-01 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) J - Other 304,878 304,878

2012-04-03 2012-03-30 4 STXS Stereotaxis, Inc.
Common Stock Warrant (right to buy) J - Other 378,673 378,673

2012-01-05 2012-01-03 4 STXS Stereotaxis, Inc.
Common Stock A - Award 17,647 245,933 7.73

2011-05-27 2011-05-25 4 STXS Stereotaxis, Inc.
Stock Option (right to buy) A - Award 12,250 12,250

2011-05-27 2011-05-25 4 STXS Stereotaxis, Inc.
Common Stock A - Award 3,150 228,286 1.40

2008-02-08 2008-02-06 4 STXS Stereotaxis, Inc.
Common Stock Warrants (right to buy) J - Other 286,123 286,123

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2013-08-20	STXS	Alafi Christopher D	22,220	3.7000	22,220	3.7000	82,214	353	2.7450	-21,220	-25.81
2013-08-19	STXS	Alafi Christopher D	239,021	3.7430	239,021	3.7430	894,656

Tarikh Fail	Tarikh Tran	Borang	Simbol Saham	Sekuriti	Kod	10b5-1	Saham	Baki Saham	Peratus Ubah	Saham harga	Tran Nilai	Baki Nilai
2021-05-28	2021-05-28	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	S - Sale	X	-38,843	95,000	-29.02	40.12	-1,558,381	3,811,400
2021-05-28	2021-05-27	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	S - Sale	X	-8,482	133,843	-5.96	40.01	-339,365	5,355,058
2021-05-25	2021-05-24	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	S - Sale	X	-26,575	142,325	-15.73	40.47	-1,075,490	5,759,893
2021-05-25	2021-05-21	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	S - Sale	X	-1,100	168,900	-0.65	40.00	-44,000	6,756,000
2021-04-02	2021-03-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		464	346,795	0.13	33.93	15,744	11,766,754
2021-01-05	2020-12-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		495	346,331	0.14	31.80	15,741	11,013,326
2020-10-02	2020-09-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		613	345,836	0.18	25.66	15,730	8,874,152
2020-09-14	2020-09-14	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		49,500	4,743,770	1.05	29.60	1,465,200	140,415,592
2020-09-11	2020-09-11	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		21,000	4,694,270	0.45	28.08	589,680	131,815,102
2020-07-02	2020-06-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		613	345,223	0.18	25.67	15,736	8,861,874
2020-05-28	2020-05-27	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2020-04-02	2020-03-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,024	344,610	0.30	15.37	15,739	5,296,656
2020-01-03	2019-12-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		422	343,586	0.12	34.31	14,479	11,788,436
2019-10-02	2019-09-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,941	343,164	0.57	7.47	14,499	2,563,435
2019-09-11	2019-09-10	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		6,240	4,673,270	0.13	11.00	68,640	51,405,970
2019-09-11	2019-09-10	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		320,095	4,667,030	7.36	10.58	3,386,605	49,377,177
2019-09-11	2019-09-10	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		155,116	4,346,935	3.70	9.59	1,487,562	41,687,107
2019-09-11	2019-09-10	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		3,549	4,191,819	0.08	8.98	31,870	37,642,535
2019-09-04	2019-08-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		125,000	4,188,270	3.08	8.52	1,065,212	35,691,180
2019-07-02	2019-06-28	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,117	341,223	0.33	12.98	14,499	4,429,075
2019-06-26	2019-06-25	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2019-06-19	2019-06-17	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	G - Gift		-400,000	340,106	-54.05
2019-06-19	2017-11-22	4/A	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		10,000	3,963,270	0.25	15.55	155,500	61,628,848
2019-06-14	2019-06-12	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		58,705	170,000	52.75	12.00	704,460	2,040,000
2019-06-14	2019-06-12	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		95,069	111,295	585.91	11.70	1,112,307	1,302,152
2019-06-14	2019-06-12	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		16,226	16,226		10.91	177,026	177,026
2019-05-15	2019-05-14	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		100,000	4,053,270	2.53	12.56	1,256,350	50,923,258
2019-04-02	2019-03-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,190	750,106	0.16	12.18	14,494	9,136,291
2019-01-03	2018-12-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,273	748,916	0.17	11.39	14,499	8,530,153
2018-10-02	2018-09-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		668	747,643	0.09	21.70	14,496	16,223,853
2018-07-03	2018-06-29	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		820	746,975	0.11	17.67	14,489	13,199,048
2018-06-20	2018-06-18	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2018-04-03	2018-03-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		688	746,155	0.09	21.05	14,482	15,706,563
2018-01-03	2017-12-29	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		1,001	745,467	0.13	14.48	14,494	10,794,362
2018-01-03	2017-12-29	4/A	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,001	745,467	0.13	14.48	14,494	10,794,362
2017-11-27	2017-11-22	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		10,000	744,466	1.36	15.55	155,500	11,576,446
2017-10-03	2017-10-02	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		258,065	3,953,270	6.98	15.50	4,000,008	61,275,685
2017-10-03	2017-09-29	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		918	734,466	0.13
2017-07-05	2017-06-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,167	733,548	0.16
2017-06-29	2017-06-27	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2017-04-04	2017-03-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		892	732,381	0.12
2017-01-03	2016-12-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		960	731,489	0.13
2016-12-07	2016-12-07	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		20,826	3,695,205	0.57	16.14	336,038	59,623,980
2016-12-07	2016-12-06	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		44,174	3,674,379	1.22	16.33	721,445	60,009,590
2016-11-17	2016-11-14	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		34,000	3,630,205	0.95	14.50	492,969	52,634,705
2016-10-04	2016-09-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		951	730,529	0.13
2016-07-05	2016-06-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		373	729,578	0.05
2016-06-15	2016-06-14	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2016-04-04	2016-03-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		377	729,205	0.05
2016-02-29	2016-02-29	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		100,000	728,828	15.90	29.70	2,970,300	21,648,378
2016-01-05	2015-12-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		195	628,828	0.03	53.79	10,489	33,824,658
2015-10-02	2015-09-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		262	628,633	0.04
2015-07-02	2015-06-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		328	628,371	0.05
2015-06-22	2015-06-16	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2015-04-02	2015-03-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		439	628,043	0.07
2015-03-12	2015-03-11	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		625,000	627,604	24,001.54	24.00	15,000,000	15,062,496
2015-01-05	2014-12-31	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		594	2,604	29.55
2014-12-03	2014-12-01	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		1,422	3,596,205	0.04	14.75	20,974	53,044,024
2014-11-28	2014-11-28	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		35,000	3,594,783	0.98	14.75	516,250	53,023,049
2014-11-21	2014-11-19	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		1,034	3,559,783	0.03	14.25	14,734	50,726,908
2014-11-18	2014-11-18	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		3,531	3,558,749	0.10	14.23	50,246	50,640,998
2014-11-18	2014-11-14	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		133	3,555,218	0.00	15.07	2,004	53,577,135
2014-11-13	2014-11-13	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		2,200	3,555,085	0.06	15.12	33,264	53,752,885
2014-11-13	2014-11-12	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		5,000	3,552,885	0.14	15.23	76,150	54,110,439
2014-11-13	2014-11-11	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	P - Purchase		5,000	3,547,885	0.14	15.55	77,750	55,169,612
2014-10-02	2014-09-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		765	2,010	61.45
2014-07-02	2014-06-30	4	ITCI	Intra-Cellular Therapies, Inc. Stock Option (right to buy)	A - Award		20,000	20,000
2014-07-02	2014-06-30	4	ITCI	Intra-Cellular Therapies, Inc. Common Stock	A - Award		1,245	1,245
2013-09-09		3	NONE	Intra-Cellular Therapies, Inc. Common Stock				3,542,885
2013-09-09		3	NONE	Intra-Cellular Therapies, Inc. Common Stock				503,753
2013-08-20	2013-08-20	4	STXS	Stereotaxis, Inc. Common Stock	S - Sale		-22,220	1,266,628	-1.72	3.70	-82,214	4,686,524
2013-08-20	2013-08-19	4	STXS	Stereotaxis, Inc. Common Stock	S - Sale		-239,021	1,288,848	-15.64	3.74	-894,656	4,824,158
2013-08-20	2013-08-16	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	M - Exercise		-261,241	606,249	-30.11	3.36	-878,031	2,037,603
2013-08-20	2013-08-16	4	STXS	Stereotaxis, Inc. Common Stock	M - Exercise		261,241	1,527,869	20.62	3.36	878,031	5,135,168
2013-08-15	2013-07-31	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	J - Other		-4,771	4,771	-50.00
2013-08-15	2013-06-28	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	J - Other		-16,129	16,129	-50.00
2012-05-14	2012-05-10	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	P - Purchase		8,674,908	8,674,908
2012-05-14	2012-05-10	4	STXS	Stereotaxis, Inc. Common Stock	P - Purchase		8,674,908	12,666,281	217.34
2012-05-14	2012-05-07	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	J - Other		781,018	781,018
2012-05-03	2012-05-01	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	J - Other		304,878	304,878
2012-04-03	2012-03-30	4	STXS	Stereotaxis, Inc. Common Stock Warrant (right to buy)	J - Other		378,673	378,673
2012-01-05	2012-01-03	4	STXS	Stereotaxis, Inc. Common Stock	A - Award		17,647	245,933	7.73
2011-05-27	2011-05-25	4	STXS	Stereotaxis, Inc. Stock Option (right to buy)	A - Award		12,250	12,250
2011-05-27	2011-05-25	4	STXS	Stereotaxis, Inc. Common Stock	A - Award		3,150	228,286	1.40
2008-02-08	2008-02-06	4	STXS	Stereotaxis, Inc. Common Stock Warrants (right to buy)	J - Other		286,123	286,123